Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions

被引：40
|
作者：
Kato, T
Kanbayashi, T
Yamamoto, K
Nakano, T
Shimizu, T
Hashimoto, T
Ikeda, S
机构：
[1] Shinshu Univ, Sch Med, Dept Internal Med 3, Matsumoto, Nagano 3908621, Japan
[2] Akita Univ, Sch Med, Dept Neuropsychiat, Akita 010, Japan
[3] Toyoshina Red Cross Hosp, Dept Neurol, Nagano, Japan
来源：
INTERNAL MEDICINE | 2003年 / 42卷 / 08期
关键词：
multiple sclerosis; hypersomnia; hypocrein; orexin; hypothalamus;
D O I：
10.2169/internalmedicine.42.743
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 45-year-old Japanese woman with multiple sclerosis (MS) manifested hypersomnia in a relapse of MS. Magnetic resonance imaging revealed new bilateral hypothalamic lesions, and the hypocretin-1 level in the cerebrospinal fluid (CSF) was significantly low. Methylprednisolone pulse treatment successfully resolved the hypersomnia and the left hypothalamic lesion, and it normalized the hypocretin-1 level in the CSF. These findings suggest that the hypothalamic hypocretin (orexin) system may be crucial to maintaining the arousal level and that lesions in the system can cause hypersomnia in MS.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 38 条
  • [31] A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions
    Nozaki, Hiroaki
    Shimohata, Takayoshi
    Kanbayashi, Takashi
    Sagawa, Youhei
    Katada, Shin-ichi
    Satoh, Masahisa
    Onodera, Osamu
    Tanaka, Keiko
    Nishizawa, Masatoyo
    SLEEP MEDICINE, 2009, 10 (02) : 253 - 255
  • [32] Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy
    Dalal, MA
    Schuld, A
    Pollmächer, T
    JOURNAL OF SLEEP RESEARCH, 2002, 11 (03) : 273 - 273
  • [33] Is there increased daytime sleepiness and low hypocretin-1 levels during multiple sclerosis attacks?
    Knudsen, S.
    Jennum, P. J.
    Nielsen, K.
    Sheikh, S. P.
    Gammeltoft, S.
    Frederiksen, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 282 - 282
  • [34] Increased CSF hypocretin-1 (Orexin-A) in early- versus late-onset restless legs syndrome (RLS): Effects of iron status and amount of activity
    Allen, RP
    Mignot, E
    Ripley, B
    Nishino, S
    Earley, CJ
    NEUROLOGY, 2002, 58 (07) : A514 - A514
  • [35] CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients (vol 474, pg 9, 2010)
    Papuc, Ewa
    Stelmasiak, Zbigniew
    Grieb, Pawel
    Rejdak, Konrad
    NEUROSCIENCE LETTERS, 2010, 479 (03) : 337 - 337
  • [36] Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder (vol 35, pg 1001, 2010)
    Strawn, Jeffrey R.
    Pyne-Geithman, Gail J.
    Ekhator, Nosakhare N.
    Horn, Paul S.
    Uhde, Thomas W.
    Shutter, Lori A.
    Baker, Dewleen G.
    Geracioti, Thomas D., Jr.
    PSYCHONEUROENDOCRINOLOGY, 2016, 63 : 410 - 410
  • [37] Normal levels of CSF hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis
    Knudsen, S.
    Jennun, P. J.
    Korsholm, K.
    Sheikh, S. P.
    Gammeltoft, S.
    Frederiksen, J. L.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 : 105 - 105
  • [38] Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: No correlation with fatigue and sleepiness
    Constantinescu, Cris S.
    Niepel, Graham
    Patterson, Michael
    Judd, Aisha
    Braitch, Manjit
    Fahey, Angela J.
    Harikrishnan, Sreedharan
    Edwards, Laura J.
    Tench, Christopher R.
    Bennett, Geoffrey W.
    Ghatei, Mohammad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 307 (1-2) : 127 - 131
1234